Clinical Relevance: A newly discovered genetic variant could provide therapeutic clues for Alzheimer's disease
- A patient with a never-before-seen genetic mutation is only the second patient to show exceptional resistance to a rare form of Alzheimer's known as ADAD.
- Despite heavy plaque buildup in the brain, the man remained cognitively healthy until his late sixties.
- The mutation, named RELN-COLBOS, appeared to mitigate tau pathologies particularly in the entorhinal cortex, a brain region associated with memory and sense of time.
Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.
SUBSCRIBE TO OUR EMAIL